Related Experiment Video
Updated: May 29, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
Published on: December 27, 2016
A rapid detection method for apoptosis and necrosis measurement using the Cellometer imaging cytometry
Leo Li-Ying Chan1, Ning Lai, Elena Wang
1Department of Technology R&D, Nexcelom Bioscience LLC, Lawrence, MA 01843, USA. lchan@nexcelom.com
Abstract:
Apoptosis and necrosis play an important role in various aspects of preclinical pharmaceutical drug discovery and validation. The ability to quickly determine the cytotoxic effect of chemical compounds on cancer cells allows researchers to efficiently identify potential drug candidates for further development in the pharmaceutical discovery pipeline. Recently, a new imaging cytometry system has been developed by Nexcelom Bioscience LLC (Lawrence, MA, USA) for fluorescence-based cell population analysis. Currently, fluorescence-based cell death assays have not been demonstrated by the Cellometer system, which can potentially provide a quick, simple, and inexpensive alternative method for smaller biomedical research laboratories. In this study, we demonstrate for the first time the use of Cellometer imaging cytometry for necrosis/apoptosis detection by studying the dose-response effect of heat and drug-induced cell death in Jurkat cells labeled with annexin V-FITC (apoptotic) and propidium iodide (necrotic). The experimental results were evaluated to validate the imaging cytometric capabilities of the Cellometer system as compared to the conventional flow cytometry. Similar cell population results were obtained from the two methods. The ability of Cellometer to rapidly and cost-effectively perform fluorescent cell-based assays has the potential of improving research efficiency, especially where a flow or laser scanning cytometer is not available or in situations where a rapid analysis of data is desired.
Insights
This study shows Cellometer imaging cytometry can detect apoptosis and necrosis. This provides a fast, cost-effective alternative for cell death assays in drug discovery.
Area of Science:
- Biomedical research
- Cell biology
- Drug discovery
Background:
- Apoptosis and necrosis are crucial in preclinical pharmaceutical drug discovery.
- Assessing compound cytotoxicity aids in identifying potential drug candidates.
- Nexcelom Bioscience LLC developed a new imaging cytometry system for cell analysis.
Purpose of the Study:
- To demonstrate Cellometer imaging cytometry for apoptosis and necrosis detection.
- To evaluate its use as a quick, simple, and inexpensive alternative for cell death assays.
- To compare its performance against conventional flow cytometry.
Main Methods:
- Utilized Cellometer imaging cytometry for fluorescence-based cell death assays.
- Studied dose-response effects of heat and drug-induced cell death in Jurkat cells.
- Labeled cells with annexin V-FITC (apoptotic) and propidium iodide (necrotic).
- Compared results with conventional flow cytometry.
Main Results:
- Cellometer imaging cytometry successfully detected apoptosis and necrosis.
- Experimental results showed similar cell population data compared to flow cytometry.
- Demonstrated dose-response effects of cell death induction.
Conclusions:
- Cellometer imaging cytometry is a viable method for apoptosis and necrosis detection.
- It offers a rapid, cost-effective alternative to traditional methods, especially for smaller labs.
- Enhances research efficiency in pharmaceutical discovery and validation.

